Projects per year
Organisation profile
Organisation profile
This research cluster focuses on optimizing the safety, effectiveness, and rational use of medicines. It integrates evidence-based pharmaceutical care with health systems research to enhance patient quality of life. Key research areas include medication safety, medicines optimization, drug-related problems, therapeutic drug monitoring, personalized medicine, medication adherence, pharmacoeconomics, pharmacy practice, medication errors, and drug use evaluation/review.
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Model Peredaran Obat Bebas/Bebas Terbatas di Hipermarket, Supermarket, dan Minimarket: Mixed-Method Study
Puspitasari, A. W. (PI)
22/10/25 → 24/08/26
Project: Research
-
Drug Related Problems in Pediatric Care in Indonesia: Assessing Pharmacist Interventions and Barriers to Improve Medication Safety
Puspitasari, A. W. (PI)
22/05/25 → 30/11/27
Project: Research
-
Bantuan Pengelolaan Kelompok Riset/Laboratorium Tahun 2025 - Clinical Pharmacy and Pharmacy Practice
Andrajati, R. (PI)
31/10/25 → 11/07/26
Project: Research
-
Adverse events in bedaquiline- and pretomanid-based regimens for drug-resistant tuberculosis from trial, implementation and pharmacovigilance studies
Maria, N., Larasati, A. L., Hamdani, I. Y., Cho, J. G. & Alffenaar, J. W. C., 2026, (Accepted/In press) In: British Journal of Clinical Pharmacology. 92, 8, p. 2607-2623 17 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Drug Safety in Hospitalized Diabetes Patients: A Retrospective Analysis of Predictors and Clinical Relevance of Potential Drug–Drug Interactions
Khan, M. A., Syafhan, N. F., Noor, S., Alshammari, M. S., Alotaibi, M., Alrohily, W., Alanazi, A. H., Alsubhi, W. A., Al Shammari, L., Imran, M. R. & Ahmad, A., 2 May 2026, In: Healthcare (Switzerland). 14, 9, 16 p., 1224.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-world predictors of severe chemotherapy-induced neutropenia in non-Hodgkin lymphoma: Evaluation of biosimilar and reference rituximab
Andriyanto, D. B., Syafhan, N. F. & Nurhayati, F., 7 May 2026, (Accepted/In press) In: Journal of Oncology Pharmacy Practice.Research output: Contribution to journal › Article › peer-review